Ojeda, Joyce <br/><br/>
Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  06 2020 
 - 1380-1384 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.1080/21645515.2019.1697595  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antibodies, Viral<br/>Child<br/>Hemagglutination Inhibition Tests<br/>Humans<br/>Immunogenicity, Vaccine<br/>Infant<br/>Influenza B virus<br/>Influenza Vaccines--adverse effects<br/>Influenza, Human--prevention & control<br/>Vaccines, Inactivated--adverse effects